Immunogenetics of longevity. Is major histocompatibility complex polymorphism relevant to the control of human longevity? A review of literature data.

Authors: Caruso C; Candore G; Romano GC; Lio D; Bonafè M; Valensin S; Franceschi C

Abstract: Literature data suggest that human longevity may be directly correlated with optimal functioning of the immune system. Therefore, it is likely that one of the genetic determinants of longevity resides in those polymorphisms for the immune system genes that regulate immune responses. Accordingly, studies performed on mice have suggested that the Major Histocompatibility Complex (MHC), known to control a variety of immune functions, is associated with the life span of the strains. In the last 25 years, a fair number of cross-sectional studies that searched for the role of HLA (the human MHC) genes on human longevity by comparing HLA antigen frequencies between groups of young and elderly persons have been published, but conflicting findings have been obtained. In fact, the same HLA antigens are increased in some studies, decreased in others and unchanged in others. On the whole, that could lead us to hypothesize that the observed age-related differences in the frequency of HLA antigens are due to bias. In our opinion, this hypothesis is real for most studies owing to major methodological problems. However, some studies that do not meet these biases have shown an association between longevity and some HLA-DR alleles or HLA-B8,DR3 haplotype, known to be involved in the antigen non-specific control of immune response. Thus, HLA studies in man may be interpreted to support suggestions derived from the studies on congenic mice on MHC effects on longevity. However, in mice the association may be by way of susceptibility to lymphomas whereas, in human beings, the effect on longevity is likely, via infectious disease susceptibility. Longevity is associated with positive or negative selection of alleles (or haplotypes) that respectively confer resistance or susceptibility to disease(s), via peptide presentation or via antigen non-specific control of the immune response.

Keywords: Aging/genetics/immunology; Animals; Genetic Predisposition to Disease; HLA Antigens/immunology; Humans; Immunogenetics; Longevity/*genetics/*immunology; Major Histocompatibility Complex/genetics/*immunology; Mice; *Polymorphism, Genetic
Journal: Mechanisms of ageing and development
Volume: 122
Issue: 5
Pages: 445-62
Date: April 9, 2001
PMID: 11292511
Select reference article to upload


Citation:

Caruso C, Candore G, Romano GC, Lio D, Bonafè M, Valensin S, Franceschi C (2001) Immunogenetics of longevity. Is major histocompatibility complex polymorphism relevant to the control of human longevity? A review of literature data. Mechanisms of ageing and development 122: 445-62.


Longevity Variant Associations (p-value):
  • -

  • Update (Admin) | Auto-Update

    Comment on This Data Unit